Follow-up of patients after curative bladder cancer treatment: guidelines vs. practice

Current Opinion in Urology
Olaf P J Vrooman, J Alfred Witjes

Abstract

Goal of surveillance after curative treatment of bladder cancer is to identify bladder cancer recurrence in an early stage. There also has to be close follow-up of the metabolic and functional consequences of urinary diversions. In this review we propose a follow-up scheme based on the available literature. Follow-up of patients who underwent curative treatment after invasive bladder cancer covers many aspects. Most recurrences are seen within 2-3 years after curative treatment, therefore awareness of specific signs and symptoms that indicate local-regional, distant, upper urinary tract and urethral recurrence are important. But apart from the oncological follow-up there are also metabolic and functional aspects that play a vital role in surveillance. At this time there is no consensus about the best follow-up strategy and a follow-up strategy based on the literature is suggested.

References

Nov 1, 1996·The Journal of Urology·J A FreemanD G Skinner
Aug 15, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D F BajorinG Higgins
Mar 19, 1999·The Journal of Urology·R D Mills, U E Studer
Jun 8, 1999·Lancet·A R Mundy
Oct 3, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D F BajorinM G Boyle
Feb 7, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J P SteinD G Skinner
Oct 31, 2001·European Urology·J Huguet-PérezJ Vicente-Rodríguez
Feb 11, 2003·The Journal of Urology·Richard E Hautmann
Feb 11, 2003·The Journal of Urology·Daniel W LinGuido Dalbagni
Apr 23, 2003·European Urology·Jorge HuguetHumberto Villavicencio
Dec 19, 2003·The Urologic Clinics of North America·Bernard H BochnerCheryl T Lee
Jan 15, 2004·Obstetrics and Gynecology Clinics of North America·Richard H Beigi, Harold C Wiesenfeld
Dec 6, 2005·Critical Reviews in Oncology/hematology·Fiona C BurkhardUrs E Studer
Jul 5, 2006·Urologic Oncology·Jennifer B Sherwood, Arthur I Sagalowsky
Jul 11, 2006·World Journal of Urology·Richard E HautmannUrs E Studer
Dec 13, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Dipen J ParekhGuido Dalbagni
Feb 7, 2007·Urology·S Bruce MalkowiczIwao Fukui
Jan 23, 2009·European Urology·Arnulf StenzlJ Alfred Witjes
Feb 24, 2009·The Journal of Urology·Bjoern G VolkmerRichard E Hautmann
Jul 10, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J BellmuntUNKNOWN ESMO Guidelines Working Group
Dec 19, 2009·Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada·Ilias Cagiannos, Christopher Morash

❮ Previous
Next ❯

Citations

Jul 25, 2013·Abdominal Imaging·Atul B ShinagareStuart G Silverman
Sep 13, 2013·Der Urologe. Ausg. A·M BöhmUNKNOWN Arbeitskreis Urinzytologie der DGU (Deutsche Gesellschaft für Urologie)
Oct 5, 2013·Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie·Y NeuzilletUNKNOWN les membres du Comité de cancérologie de l’Association française d’urologie
Apr 9, 2016·Radiographics : a Review Publication of the Radiological Society of North America, Inc·Lauren N MoomjianAdam P Klausner
Aug 24, 2019·Abdominal Radiology·Abdul RazikSadhna Verma
Mar 23, 2019·International Braz J Urol : Official Journal of the Brazilian Society of Urology·Yun-Sok HaEun Sang Yoo
Jul 8, 2017·World Journal of Urology·Suzanne B MerrillIgor Frank
Apr 18, 2018·Der Urologe. Ausg. A·P OlbertA Hegele

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.